RNF4 sustains Myc-driven tumorigenesis by facilitating DNA replication.

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• RNF4 (SUMO-targeted E3 ubiquitin ligase) is known to regulate DNA repair.
• The role of RNF4 as a tumor suppressor has not been previously investigated.
• Tumorigenesis is often linked to genomic instability and DNA repair pathway dysregulation.

Purpose of the Study:

• To investigate the role of RNF4 in B cell lineage and its impact on somatic cell growth.
• To determine the importance of RNF4 in tumor suppression.
• To explore the functional consequences of RNF4 deficiency in DNA replication and stress response.

Main Methods:

• Conditional knockout mouse model to delete Rnf4 in B cells.
• Assessment of genomic instability in Rnf4-deficient B cells.
• Analysis of DNA replication, ATR-CHK1 signaling, and protein accumulation at replication forks.
• Evaluation of lifespan in mice with oncogenic c-myc and Rnf4 deletion.

Main Results:

• Rnf4-conditional-knockout B cells displayed significant genomic instability but did not show increased tumor susceptibility.
• Rnf4 deletion prolonged the healthy lifespan of mice harboring an oncogenic c-myc transgene.
• RNF4 deficiency impaired ATR-CHK1 signaling, reduced replication fork stability factors, and led to accumulation of hyper-SUMOylated proteins.
• Replication failure in RNF4-deficient cells involved the SMC5/6 complex and RAD51.

Conclusions:

• RNF4 is essential for normal DNA replication and maintaining genomic stability.
• Despite causing instability, RNF4 deficiency can suppress tumor growth in specific contexts, like c-myc-driven cancers.
• RNF4, upregulated in several human tumors, represents a potential therapeutic target for anticancer strategies, particularly in c-myc-positive tumors.